Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Quercetin Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 9 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 73 13
Myricetin Potential treatment - theoretical effect Natural product Antiviral Dec/28/2020 4 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/22/2020 24 5
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2020 26 3
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
25-hydroxycholesterol  Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020 3 0
Luteolin Potential treatment - theoretical effect Natural product Antiviral Nov/07/2020 3 0
Anti-SARS-CoV-2 monobody clone 6b Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020 1 0
Bedoradrine Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 1 0